Jpmorgan Chase & Co »

Inmune Bio Ord shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Inmune Bio Ord (INMB) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Inmune Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Inmune Bio Ord held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmune Bio Ord by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $39k 3.5k 11.26
2020-06-30 $0 3 0.00

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Inmune Bio Ord

Vanguard Group
Janney Montgomery Scott
Deutsche Bank Aktiengesellschaft
MAI Wealth Advisors
Quadrant Capital
Royal Bank of Canada
Citadel Advisors
UBS Group
Jane Street
Citigroup
Westside Investment Management
Fermata Advisors
Bank of New York Mellon
Millennium Management
Balyasny Asset Management

View all funds holding Inmune Bio Ord